The G2 on 5G Podcast: Mavenir's Woes, Trump's Spectrum Plans, Rip and Replace Funding, MediaTek's Pixel Potential, 2024 Recap, and 2025 Predictions
Welcome and Introduction
- Will Townsend and Anshel Sag host the final episode of G2 and 5G for 2024
- Apology for delay due to travel commitments
- Brief discussion on upcoming CES expectations
Hot Takes on Recent News
- Mavenir's ongoing challenges and executive departure
- Potential Trump administration's plans for 3 GHz spectrum allocation
Mavenir's Struggles
- John Baker's departure and its implications
- Financial difficulties and failed expansion attempts
- Speculation on potential buyers and future prospects
Spectrum Allocation and FCC Changes
- Discussion on lower 3 GHz band allocation for 5G
- Challenges with FCC's ability to allocate spectrum
- Congressional issues affecting spectrum allocation
Rip and Replace Funding
- US Senate's approval of $3 billion for replacing Chinese infrastructure
- Debate on whether the allocated funds are sufficient
MediaTek's Potential Entry into Pixel Phones
- Rumors of MediaTek 5G modems in future Pixel devices
- Comparison with current Samsung modems in Pixel devices
- Speculation on Apple's modem strategy
2024 Retrospective and 2025 Predictions
- 2024 as a setup year for significant 5G developments in 2025
- Predictions for satellite integration in 5G networks
- AI's increasing role in network operations and device interfaces
The Year of LEO (Low Earth Orbit) Satellites
- 2025 projected as the "year of the fifth zodiac" (Leo)
- Anticipated developments in LEO satellite communications
- Potential scaling of direct-to-cell unmodified technology
Closing Thoughts
- Brief mention of upcoming phone reviews
- Expectations for 5G advancements and glimpses of 6G in 2025
- Invitation for audience engagement and feedback
D'autres épisodes de "The G2 on 5G Podcast by Moor Insights & Strategy"
Ne ratez aucun épisode de “The G2 on 5G Podcast by Moor Insights & Strategy” et abonnez-vous gratuitement à ce podcast dans l'application GetPodcast.